Jiyun ZHANG1 and Jian LU1
1Department of Radiology,the Third People’s Hospital of Nantong, Nantong, China
Synopsis
The aim of this
study is to investigate the value of Gd-EOB-DTPA-enhanced MRI in evaluating
segmental liver function. Statistical analysis was used to evaluate the
relationship between the △LMR of each
liver segment and liver function,as well as the△LMR
of different liver segments. Our quantitative
study demonstrated that Gd-EOB-DTPA intake into hepatocytes was strongly
affected by liver function .The segmental liver function can be evaluated via
Gd-EOB-DTPA-enhanced MRI and calculation of the △LMR
may be a novel optional.
Introduction
Assessing regional liver function plays a significant role in clinical practice, especially for surgeons, providing valuable informationto predict postoperative risk after partial liver resection.Gd-EOB-DTPA is the hepatocyte-specific MR contrast agent. It could be transported some 50% doses into hepatocytes after intravenous injection via organic anion transport polypeptide(OATP)on the surface of the liver sinus, and eventually was excreted into the bile through another carrier protein multidrug resistance-associated protein (MRP). Recently,studies have confirmed that gadoxetic acid-enhanced MR imaging of hepatocyte-phase could reflect the function of liver function1-3. However,few research has been performed on segmental liver function evaluation4. The purpose of this study is to investigate the efficiency of Gd-EOB-DTPA-enhanced MRI in evaluating each segment liver function.Methods
A
total of 124 patients were classified into the 4 groups: patients with normal
liver function(NLF)group (n=21); hepatitis B cirrhosis patients with Child–Pugh A(CPA)
group(n=48);hepatitis B cirrhosis patients with Child–Pugh B (CPB) group(n=40);hepatitis
B cirrhosis patients with Child–Pugh C(CPC) group(n=15). All patients underwent
Gd-EOB-DTPA-enhanced MRI examination according to the clinical needs and the
serological examination indicators were obtained within one week before and
after the imaging examination.The increase rate of liver muscle signal ratio (△LMR)was calculated the signal
intensity of liver parenchyma and erector spinal muscle before(SI
pre) and 3min、10min、20
min after (SI
post) Gd-EOB-DTPA intravenous administration, using the
following formula: LMR=SI
(liver)/SI
(muscle);△LMR=LMR
post-
LMR
pre/LMR
pre.The one way ANOVA was used to compare the △LMR of each liver segment.Between
different liver segments were compared using two way ANOVA considering only the
main effect. ROC curve of △LMR was
used to analyze the diagnosis efficiency between NLF-CPA and CPB-CPC group.Spearman
rank correlation was used to analyzed the correlation of △LMR with Child-Pugh score and model
for end-stage liver disease (MELD) score.
Results
After 3min、10min and 20min
injection of Gd-EOB-DTPA,△LMR showed significant
difference (P < 0.05) in each liver segment of different groups.The △LMRvaried
significantly at different time points of each liver segment in NLF,CPA,CPB
group (P < 0.05),but no significant difference in CPC groups(P>0.05)(table1).
△LMR of
most liver segment showed a decreasing trend with the increase of the degree of
impaired liver function,and the trend is more obvious at 10min and 20min after
contrast agent administration. Generally,the△LMR
values of normal liver function were higher than abnormal liver function group,△LMR
values of CPC group is the lowest.The △LMR10min
diagnostic efficacy is the highest in NLF-CPA and CPB-CPCgroups(table2). The△LMR had
significant negative correlations with Child-Pugh score and MELD score (P <
0.05) (figure1).Discussion
As
previously reported that hepatic enhancement with Gd-EOB-DTPA is strongly
affected by the degree of liver cirrhosis, which is classified by the Child-Pugh
score 5.
Gd-EOB-DTPA
is the hepatocyte-specific MR contrast agent, absorbed by normal hepatocytes
after injecting, and then liver parenchyma shows the high signal. With increasing
damage of liver, contrast agent intake was decreased or none and sequent showing
low signal in parenchyma. The changes were directly indicated in the signal
intensity of liver parenchyma.
In
our study,we analyzed the△LMR after 3min、10min、20min
of Gd-EOB-DTPA enhancement of each liver segment. The △LMR varied
significantly at different time points of each liver segment in NLF,CPA,CPB
group.There was no significant difference of CPC group between different liver
segment.However, the mechanism remained unclear.We hypothesized that the
distribution of hepatocytes and bile ducts in liver segments is different, as
well as the blood vessels. This difference suggested the changes in the△LMR. Severe
damage and relatively equal on the liver function of CPC group could explained
the phenomenon.
Based
on clinical demand, we put NLF and CPA inNLF-CPA group in which the patients
could get better prognosis, but CPB and CPC in CPB-CPC group whose prognosis
were poor. The ROC curve was used for further analysis between the two groups.In
our study, △LMR used to examine the diagnostic efficiency of between
NLF-CPA and CPB-CPC groups of each segmentat different time points. At 10min
after injection,the AUC of △LMRwas above 0.8,some
segment is close to 0.9.It demonstrated that the △LMR at
10min may be efficient for evaluation of liver function.Conclusion
This study showed that
Gd-EOB-DTPA intake into hepatocytes was strongly affected by liver function.Segmental
liver function could be efficiently evaluated byGd-EOB-DTPA-enhanced MRI.Acknowledgements
No acknowledgement found.References
1.
Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T,et al. Liver
parenchymal enhancement of hepatocyte-phase images inGd-EOB-DTPA-enhanced MR
imaging: which biological markers ofthe liver function affect the
enhancement[J]? J Magn Reson Imaging .2009,30(5):1042–6.
2. Haimerl M, Verloh
N, Zeman F, et al. Gd-EOB-DTPA-enhanced MRI for evaluation of Liver function:
Comparison between signal-intensity-based indices and T1 relaxometry[J]. Sci
Rep, 2017,7:43347.
3. Verloh N , Haimerl
M, Zeman F, et al.Assessing liver function by liver enhancement during the
hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla [J]. EurRadiol.
2014,24(5):1013-9.
4. ZP Zhou ,LL
Long ,WJ Qiu ,et al. Evaluating segmental liver function usingT1
mapping on Gd-EOB-DTPA-enhancedMRI with a 3.0 Tesla [J]. BMC Med
Imaging. 2017,17(1):20.
5. Verloh N, Haimerl
M, Rennert J et al Impact of liver cirrhosison liver enhancement at
Gd-EOB-DTPA enhanced MRI at 3Tesla[J].Eur J Radiol .2013,82(10):1710–1715.